Meyka AI API is live for developers.Start building.
Advertisement
Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc. (NVOS) Stock Overview

Explore Novo Integrated Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

NVOSNASDAQ
HealthcareMedical - Care Facilities
$0.02
$0.00(0.00%)
U.S. Market opens in 51h 50m
Advertisement

Novo Integrated Sciences, Inc. (NVOS)

Meyka AI Score

Z

Key Financials

Market Cap394.6K
P/E Ratio-0.02
EPS (TTM)$-1.33
ROE-0.81%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.42
1 Year Target$0.00

NVOS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novo Integrated Sciences, Inc. (NVOS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.02 and a market capitalization of 394.6K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
545.16%
3-Month Change
545.16%
6-Month Change
852.38%
Year-to-Date (YTD) Change
640.74%
1-Year Change
233.33%
3-Year Change
-98.41%
5-Year Change
-99.92%
All-Time (Max) Change
-99.50%

Contact Information

206 617 9797
11120 NE 2nd Street, Bellevue, WA, 98004

Company Facts

1,150 Employees
IPO DateFeb 23, 2021
CountryUS
Actively Trading

Frequently Asked Questions